Darrell Thigpen
Internal Medicine · Dallas, TXNPI 1467468785
Payments from drug & device makers
Across 93 payments — averaging $14.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$149
- Merck$140
- Pfizer$137
- Boehringer Ingelheim$130
- Amarin Pharma, Inc.$122
- Amgen$119
- plus $593 from 14 others
What the payments were for
- Food & beverage$1,390100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 11 | $149 |
| Merck | 15 | $140 |
| Pfizer | 9 | $137 |
| Boehringer Ingelheim | 7 | $130 |
| Amarin Pharma, Inc. | 6 | $122 |
| Amgen | 7 | $119 |
| AstraZeneca | 8 | $112 |
| Novartis | 4 | $71 |
| Astellas Pharma US Inc | 3 | $70 |
| Sanofi-aventis U.S. LLC | 5 | $68 |
| GSK | 3 | $48 |
| Kowa Pharmaceuticals America, Inc. | 3 | $48 |
| Johnson & Johnson | 3 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Hologic Sales And Service, LLC | 1 | $22 |
| AbbVie | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$1,390 in reported general payments places this provider in the 70th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in Dallas
- Amit VermaDallas$7.7M
- Valentine EbuhDallas$6.8M
- Gary SinclairDallas$3.4M
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.